7-hydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

Details

Top
Internal ID 7da589e7-caed-4e79-99a8-b440f59a2e87
Taxonomy Phenylpropanoids and polyketides > Coumarins and derivatives > Coumarin glycosides
IUPAC Name 7-hydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
SMILES (Canonical) C1=CC(=C(C2=C1C=CC(=O)O2)OC3C(C(C(C(O3)CO)O)O)O)O
SMILES (Isomeric) C1=CC(=C(C2=C1C=CC(=O)O2)O[C@H]3[C@@H]([C@@H]([C@@H]([C@H](O3)CO)O)O)O)O
InChI InChI=1S/C15H16O9/c16-5-8-10(19)11(20)12(21)15(22-8)24-14-7(17)3-1-6-2-4-9(18)23-13(6)14/h1-4,8,10-12,15-17,19-21H,5H2/t8-,10-,11-,12-,15+/m1/s1
InChI Key MMPBHSBVPREJQC-WSWLIKMPSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H16O9
Molecular Weight 340.28 g/mol
Exact Mass 340.07943208 g/mol
Topological Polar Surface Area (TPSA) 146.00 Ų
XlogP -0.60
Atomic LogP (AlogP) -1.32
H-Bond Acceptor 9
H-Bond Donor 5
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 7-hydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5923 59.23%
Caco-2 - 0.9262 92.62%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability - 0.7571 75.71%
Subcellular localzation Mitochondria 0.5362 53.62%
OATP2B1 inhibitior - 0.5708 57.08%
OATP1B1 inhibitior + 0.9185 91.85%
OATP1B3 inhibitior + 0.9389 93.89%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.8000 80.00%
BSEP inhibitior - 0.9475 94.75%
P-glycoprotein inhibitior - 0.8926 89.26%
P-glycoprotein substrate - 0.9635 96.35%
CYP3A4 substrate - 0.5540 55.40%
CYP2C9 substrate - 0.8141 81.41%
CYP2D6 substrate - 0.8577 85.77%
CYP3A4 inhibition - 0.9207 92.07%
CYP2C9 inhibition - 0.9414 94.14%
CYP2C19 inhibition - 0.9119 91.19%
CYP2D6 inhibition - 0.9327 93.27%
CYP1A2 inhibition - 0.9045 90.45%
CYP2C8 inhibition - 0.7995 79.95%
CYP inhibitory promiscuity - 0.8472 84.72%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.7090 70.90%
Eye corrosion - 0.9928 99.28%
Eye irritation - 0.6922 69.22%
Skin irritation - 0.7983 79.83%
Skin corrosion - 0.9715 97.15%
Ames mutagenesis - 0.6400 64.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7520 75.20%
Micronuclear + 0.6033 60.33%
Hepatotoxicity - 0.5125 51.25%
skin sensitisation - 0.8796 87.96%
Respiratory toxicity + 0.5222 52.22%
Reproductive toxicity + 0.6889 68.89%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.6500 65.00%
Acute Oral Toxicity (c) III 0.4513 45.13%
Estrogen receptor binding - 0.4886 48.86%
Androgen receptor binding + 0.6202 62.02%
Thyroid receptor binding - 0.5175 51.75%
Glucocorticoid receptor binding + 0.7773 77.73%
Aromatase binding - 0.5077 50.77%
PPAR gamma + 0.6018 60.18%
Honey bee toxicity - 0.8419 84.19%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.7750 77.50%
Fish aquatic toxicity + 0.7790 77.90%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.20% 91.11%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 90.20% 94.00%
CHEMBL2581 P07339 Cathepsin D 88.80% 98.95%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 85.90% 99.15%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.46% 95.56%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 85.29% 99.23%
CHEMBL3401 O75469 Pregnane X receptor 84.00% 94.73%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 82.69% 86.92%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.70% 97.09%

Plants that contains it

Top

Cross-Links

Top
PubChem 22524175
NPASS NPC259150
LOTUS LTS0086991
wikiData Q105167953